Synthesis and cytotoxic activities of 4,5-diarylisoxazoles.

[1]  A. McGown,et al.  Differential cytotoxicity of Combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines , 2008, Cancer Chemotherapy and Pharmacology.

[2]  C. Monneret,et al.  Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation. , 2006, Bioorganic & medicinal chemistry.

[3]  G. Tron,et al.  Synthesis and cytotoxic evaluation of combretafurazans. , 2005, Journal of medicinal chemistry.

[4]  G. Giannini,et al.  Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines. , 2005, Journal of medicinal chemistry.

[5]  Wan-Jr Syu,et al.  Antimicrobial activities of naphthazarins from Arnebia euchroma. , 2002, Journal of natural products.

[6]  N. Nam,et al.  Synthesis and anti-tumor activity of novel combretastatins: combretocyclopentenones and related analogues. , 2002, Bioorganic & medicinal chemistry letters.

[7]  S. Rosenberg,et al.  Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation. , 2002, Journal of medicinal chemistry.

[8]  N. Nam,et al.  Synthesis and cytotoxicity of 3,4-diaryl-2(5H)-furanones. , 2002, Bioorganic & medicinal chemistry letters.

[9]  N. Nam,et al.  Combretoxazolones: synthesis, cytotoxicity and antitumor activity. , 2001, Bioorganic & medicinal chemistry letters.

[10]  V. Villalobos,et al.  Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin. , 2000, Bioorganic & medicinal chemistry.

[11]  D. Chaplin,et al.  Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate. , 1999, Anticancer research.

[12]  R. Nakagawa,et al.  Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analogues. , 1998, Bioorganic & medicinal chemistry letters.

[13]  Y. Koiso,et al.  Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells. , 1998, Bioorganic & medicinal chemistry letters.

[14]  N. Lawrence,et al.  Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle , 1998, Medicinal research reviews.

[15]  C. C. Chen,et al.  Selective cytotoxicity of ginkgetin from Selaginella moellendorffii. , 1997, Journal of natural products.

[16]  R. SanMartin,et al.  A Convenient One-Pot Preparative Method for 4,5-Diarylisoxazoles Involving Amine Exchange Reactions , 1996 .

[17]  E. Hamel.  Antimitotic natural products and their interactions with tubulin , 1996, Medicinal research reviews.

[18]  M. Boyd,et al.  Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a) , 1995, Journal of medicinal chemistry.

[19]  M. Medarde,et al.  A versatile approach to the synthesis of combretastatins. , 1994, Journal of natural products.

[20]  R. SanMartin,et al.  A convenient alternative route to β-aminoketones , 1994 .

[21]  M. Cushman,et al.  Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents. , 1992, Journal of medicinal chemistry.

[22]  Ernest Hamel,et al.  Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization. , 1991, Journal of medicinal chemistry.

[23]  E. Hamel,et al.  Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin. , 1989, Biochemistry.

[24]  G. Cragg,et al.  Isolation and structure of combretastatin , 1982 .